Helen Wheeler

Helen Wheeler

UNVERIFIED PROFILE

Are you Helen Wheeler?   Register this Author

Register author
Helen Wheeler

Helen Wheeler

Publications by authors named "Helen Wheeler"

Are you Helen Wheeler?   Register this Author

57Publications

1796Reads

10Profile Views

Molecular and clonal evolution in recurrent metastatic gliosarcoma.

Cold Spring Harb Mol Case Stud 2020 Feb 3;6(1). Epub 2020 Feb 3.

Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, New South Wales 2065, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a004671DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996521PMC
February 2020

Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer.

Front Oncol 2019 14;9:1504. Epub 2020 Jan 14.

Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, The University of Sydney Northern Clinical School and Northern Sydney Local Health District, St Leonards, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.01504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971197PMC
January 2020

Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma.

Cancer 2019 Oct 28;125(19):3457-3466. Epub 2019 Jun 28.

Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32352DOI Listing
October 2019

Identifying key needs for the integration of social-ecological outcomes in arctic wildlife monitoring.

Conserv Biol 2019 08 25;33(4):861-872. Epub 2019 Jan 25.

Centre d'Ecologie Fonctionnelle et Evolutive, UMR 5175, Centre National de la Recherche Scientifique - Université de Montpellier - Université Paul-Valéry Montpellier - EPHE, 1919 route de Mende, Montpellier, 34090, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cobi.13257DOI Listing
August 2019

Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.

BMC Cancer 2019 May 14;19(1):445. Epub 2019 May 14.

Central Coast Cancer Centre, Gosford Hospital, Gosford, NSW, 2250, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5678-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518639PMC
May 2019

Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management.

J Med Imaging Radiat Oncol 2019 Apr 24;63(2):272-280. Epub 2019 Jan 24.

Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1754-9485.12850DOI Listing
April 2019

Tumour volume reduction following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic glioma.

J Clin Neurosci 2019 Jan 14;59:68-74. Epub 2018 Nov 14.

Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Sydney NeuroOncology Group, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2018.11.005DOI Listing
January 2019

Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.

Pract Radiat Oncol 2018 Jul - Aug;8(4):230-238. Epub 2018 Jan 31.

Sydney Vital, Northern Translational Cancer Research Centre, St Leonards, NSW, Australia; Department of Radiation Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Sydney Neuro-Oncology Group, North Shore Private Hospital, St Leonards, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2018.01.006DOI Listing
December 2018

Anti-angiogenic therapy for high-grade glioma.

Cochrane Database Syst Rev 2018 11 22;11:CD008218. Epub 2018 Nov 22.

Medical Oncology, Alfred Hospital, Commercial Road, Melbourne, Victoria, Australia, 3004.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/14651858.CD008218.pub4
Publisher Site
http://dx.doi.org/10.1002/14651858.CD008218.pub4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516839PMC
November 2018

ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.

Clin Lung Cancer 2018 09 5;19(5):457-459. Epub 2018 Jun 5.

Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, Royal North Shore Hospital, St Leonards, Australia; Northern Sydney Cancer Centre, Northern Sydney Local Health District, Royal North Shore Hospital, St Leonards, Australia; Sydney Medical School, Northern Clinical School, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.05.015DOI Listing
September 2018

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment.

Front Oncol 2018 13;8:314. Epub 2018 Aug 13.

The Brain Cancer Group, Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, St Leonards, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099184PMC
August 2018

Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals.

Radiat Oncol 2018 Jul 20;13(1):133. Epub 2018 Jul 20.

Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-018-1078-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053721PMC
July 2018

The development of a district nursing caseload review tool.

Br J Community Nurs 2018 Jun;23(6):220-226

District Nurse and Operational Manager, SSOTP.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/bjcn.2018.23.6.220DOI Listing
June 2018

The development of a district nursing caseload review tool.

Br J Community Nurs 2018 Jun;23(6):272-278

District Nurse and Operational Manager, SSOTP.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/bjcn.2018.23.6.272DOI Listing
June 2018

Survival improvements with adjuvant therapy in patients with glioblastoma.

ANZ J Surg 2018 Mar 18;88(3):196-201. Epub 2017 Sep 18.

Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.14153DOI Listing
March 2018

Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.

J Med Imaging Radiat Oncol 2018 Feb 5;62(1):122-127. Epub 2017 Oct 5.

Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1754-9485.12676DOI Listing
February 2018

Wildlife species benefitting from a greener Arctic are most sensitive to shrub cover at leading range edges.

Glob Chang Biol 2018 01 5;24(1):212-223. Epub 2017 Sep 5.

Department of Bioscience, Section for Ecoinformatics and Biodiversity, Aarhus University, Aarhus C, Denmark.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/gcb.13837
Publisher Site
http://dx.doi.org/10.1111/gcb.13837DOI Listing
January 2018

Leptomeningeal melanoma-A case series in the era of modern systemic therapy.

Pigment Cell Melanoma Res 2018 01 17;31(1):120-124. Epub 2017 Oct 17.

Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12652DOI Listing
January 2018

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial.

Neurooncol Pract 2017 Sep 25;4(3):171-181. Epub 2017 May 25.

Prince of Wales Hospital, Barker Street, Randwick, Sydney, NSW 2031, Australia (E.J.H.); University of New South Wales, Sydney, NSW 2052, Australia (E.J.H.); Royal Melbourne Hospital, Grattan Street, Parkville 3050, Melbourne Victoria, Australia (K.M.F., M.A.R., P.P., C.G.); Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Grattan Street Parkville 3052, Victoria, Australia (K.M.F., M.A.R.); National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Sydney, NSW 2006, Australia (E.H.B., K.S., A.L., J.S.); Austin Hospital, 145 Studley Road, Heidelberg, Melbourne, Victoria 3084, Australia (L.C.); Sir Charles Gairdner Hospital, Nedlands, Perth 6009, Western Australia (A.K.N.); Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia (H.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npw025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655481PMC
September 2017

Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.

Int J Radiat Oncol Biol Phys 2017 07 21;98(4):802-810. Epub 2017 Feb 21.

Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Sydney NeuroOncology Group, Sydney, New South Wales, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.02.028DOI Listing
July 2017

Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Authors:
Florence M G Cavalli Marc Remke Ladislav Rampasek John Peacock David J H Shih Betty Luu Livia Garzia Jonathon Torchia Carolina Nor A Sorana Morrissy Sameer Agnihotri Yuan Yao Thompson Claudia M Kuzan-Fischer Hamza Farooq Keren Isaev Craig Daniels Byung-Kyu Cho Seung-Ki Kim Kyu-Chang Wang Ji Yeoun Lee Wieslawa A Grajkowska Marta Perek-Polnik Alexandre Vasiljevic Cecile Faure-Conter Anne Jouvet Caterina Giannini Amulya A Nageswara Rao Kay Ka Wai Li Ho-Keung Ng Charles G Eberhart Ian F Pollack Ronald L Hamilton G Yancey Gillespie James M Olson Sarah Leary William A Weiss Boleslaw Lach Lola B Chambless Reid C Thompson Michael K Cooper Rajeev Vibhakar Peter Hauser Marie-Lise C van Veelen Johan M Kros Pim J French Young Shin Ra Toshihiro Kumabe Enrique López-Aguilar Karel Zitterbart Jaroslav Sterba Gaetano Finocchiaro Maura Massimino Erwin G Van Meir Satoru Osuka Tomoko Shofuda Almos Klekner Massimo Zollo Jeffrey R Leonard Joshua B Rubin Nada Jabado Steffen Albrecht Jaume Mora Timothy E Van Meter Shin Jung Andrew S Moore Andrew R Hallahan Jennifer A Chan Daniela P C Tirapelli Carlos G Carlotti Maryam Fouladi José Pimentel Claudia C Faria Ali G Saad Luca Massimi Linda M Liau Helen Wheeler Hideo Nakamura Samer K Elbabaa Mario Perezpeña-Diazconti Fernando Chico Ponce de León Shenandoah Robinson Michal Zapotocky Alvaro Lassaletta Annie Huang Cynthia E Hawkins Uri Tabori Eric Bouffet Ute Bartels Peter B Dirks James T Rutka Gary D Bader Jüri Reimand Anna Goldenberg Vijay Ramaswamy Michael D Taylor

Cancer Cell 2017 06;31(6):737-754.e6

The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A1, Canada; Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.05.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163053PMC
June 2017

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.

Neuro Oncol 2016 08 21;18(8):1146-56. Epub 2016 Feb 21.

Medical Oncology Department, Bellaria-Maggiore Hospitals, Azienda USL - IRCCS Institute of Neurological Sciences, Bologna, Italy (A.A.B.); Hôpital Avicenne, Paris 13 University, Bobigny, France (A.F.C.); University of California San Diego Health System, La Jolla, California (S.K.); Hospital Universitario 12 de Octubre, Madrid, Spain (J.M.S.-S.); Department of Oncology, Royal North Shore Hospital, St Leonards, Australia (H.R.W.); CHU Hôspital De La Timone, Rue Saint Pierre, France (O.C.); Austin Hospital, Heidelberg, Australia (L.C.); Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Frankfurt, Germany (J.P.S.); Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany (D.C.); Antwerp University Hospital, Edegem, Belgium (P.S.); Medical Oncology, Vall d'Hebron University Hospital and Universitat Autònoma de Barcelona, Barcelona, Spain (J.R.); Eli Lilly and Company, Erl Wood, England (A.C., C.S., I.G., C.M.); Eli Lilly and Company, Indianapolis, Indiana (S.C.G., D.D., M.M.L.); Neurology Clinic, University of Heidelberg, Heidelberg, Germany (W.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933481PMC
August 2016

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Authors:
Vijay Ramaswamy Thomas Hielscher Stephen C Mack Alvaro Lassaletta Tong Lin Kristian W Pajtler David T W Jones Betty Luu Florence M G Cavalli Kenneth Aldape Marc Remke Martin Mynarek Stefan Rutkowski Sridharan Gururangan Roger E McLendon Eric S Lipp Christopher Dunham Juliette Hukin David D Eisenstat Dorcas Fulton Frank K H van Landeghem Mariarita Santi Marie-Lise C van Veelen Erwin G Van Meir Satoru Osuka Xing Fan Karin M Muraszko Daniela P C Tirapelli Sueli M Oba-Shinjo Suely K N Marie Carlos G Carlotti Ji Yeoun Lee Amulya A Nageswara Rao Caterina Giannini Claudia C Faria Sofia Nunes Jaume Mora Ronald L Hamilton Peter Hauser Nada Jabado Kevin Petrecca Shin Jung Luca Massimi Massimo Zollo Giuseppe Cinalli László Bognár Almos Klekner Tibor Hortobágyi Sarah Leary Ralph P Ermoian James M Olson Jeffrey R Leonard Corrine Gardner Wieslawa A Grajkowska Lola B Chambless Jason Cain Charles G Eberhart Sama Ahsan Maura Massimino Felice Giangaspero Francesca R Buttarelli Roger J Packer Lyndsey Emery William H Yong Horacio Soto Linda M Liau Richard Everson Andrew Grossbach Tarek Shalaby Michael Grotzer Matthias A Karajannis David Zagzag Helen Wheeler Katja von Hoff Marta M Alonso Teresa Tuñon Ulrich Schüller Karel Zitterbart Jaroslav Sterba Jennifer A Chan Miguel Guzman Samer K Elbabaa Howard Colman Girish Dhall Paul G Fisher Maryam Fouladi Amar Gajjar Stewart Goldman Eugene Hwang Marcel Kool Harshad Ladha Elizabeth Vera-Bolanos Khalida Wani Frank Lieberman Tom Mikkelsen Antonio M Omuro Ian F Pollack Michael Prados H Ian Robins Riccardo Soffietti Jing Wu Phillipe Metellus Uri Tabori Ute Bartels Eric Bouffet Cynthia E Hawkins James T Rutka Peter Dirks Stefan M Pfister Thomas E Merchant Mark R Gilbert Terri S Armstrong Andrey Korshunov David W Ellison Michael D Taylor

J Clin Oncol 2016 07 6;34(21):2468-77. Epub 2016 Jun 6.

Vijay Ramaswamy, Stephen C. Mack, Alvaro Lassaletta, Betty Luu, Florence M.G. Cavalli, Uri Tabori, Ute Bartels, Eric Bouffet, Cynthia E. Hawkins, James T. Rutka, Peter Dirks, and Michael D. Taylor, The Hospital for Sick Children; Vijay Ramaswamy, Kenneth Aldape, James T. Rutka, and Michael D. Taylor, University of Toronto; Kenneth Aldape, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario; Christopher Dunham and Juliette Hukin, British Columbia Children's Hospital; Juliette Hukin, University of British Columbia, Vancouver, British Columbia; David D. Eisenstat, Dorcas Fulton, and Frank K.H. van Landeghem, University of Alberta, Edmonton; Jennifer A. Chan, University of Calgary, Calgary, Alberta; Nada Jabado and Kevin Petrecca, McGill University, Montreal, Quebec, Canada; Thomas Hielscher, Kristian W. Pajtler, David T.W. Jones, Marcel Kool, Stefan M. Pfister, and Andrey Korshunov, German Cancer Research Center; Stefan M. Pfister, University Hospital Heidelberg, Heidelberg; Marc Remke, University Hospital Düsseldorf, Düsseldorf; Martin Mynarek, Stefan Rutkowski, and Katja von Hoff, University Medical Center Hamburg-Eppendorf, Hamburg; Ulrich Schüller, Ludwig-Maximilians-Universität, Munich, Germany; Stephen C. Mack, Cleveland Clinic Foundation, Cleveland; Maryam Fouladi, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Tong Lin, Amar Gajjar, Thomas E. Merchant, and David W. Ellison, St Jude Children's Research Hospital, Memphis; Lola B. Chambless, Vanderbilt Medical Center, Nashville, TN; Sridharan Gururangan, Roger E. McLendon, and Eric S. Lipp, Duke University, Durham; Jing Wu, University of North Carolina at Chapel Hill, Chapel Hill, NC; Mariarita Santi, Children's Hospital of Philadelphia; Lyndsey Emery, Hospital of the University of Pennsylvania, Philadelphia; Ronald L. Hamilton and Ian F. Pollack, University of Pittsburgh School of Medicine; Frank Lieberman, University of Pittsburgh Medical Cen

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962737PMC
July 2016

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

J Neurooncol 2016 05 15;128(1):67-74. Epub 2016 Feb 15.

Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, 2065, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-016-2074-4
Publisher Site
http://dx.doi.org/10.1007/s11060-016-2074-4DOI Listing
May 2016

Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.

Sci Rep 2016 Mar 4;6:22477. Epub 2016 Mar 4.

Sydney Neuro-Oncology Group, Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, St Leonards, NSW, Australia, 2065.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep22477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778014PMC
March 2016

Divergent clonal selection dominates medulloblastoma at recurrence.

Authors:
A Sorana Morrissy Livia Garzia David J H Shih Scott Zuyderduyn Xi Huang Patryk Skowron Marc Remke Florence M G Cavalli Vijay Ramaswamy Patricia E Lindsay Salomeh Jelveh Laura K Donovan Xin Wang Betty Luu Kory Zayne Yisu Li Chelsea Mayoh Nina Thiessen Eloi Mercier Karen L Mungall Yusanne Ma Kane Tse Thomas Zeng Karey Shumansky Andrew J L Roth Sohrab Shah Hamza Farooq Noriyuki Kijima Borja L Holgado John J Y Lee Stuart Matan-Lithwick Jessica Liu Stephen C Mack Alex Manno K A Michealraj Carolina Nor John Peacock Lei Qin Juri Reimand Adi Rolider Yuan Y Thompson Xiaochong Wu Trevor Pugh Adrian Ally Mikhail Bilenky Yaron S N Butterfield Rebecca Carlsen Young Cheng Eric Chuah Richard D Corbett Noreen Dhalla An He Darlene Lee Haiyan I Li William Long Michael Mayo Patrick Plettner Jenny Q Qian Jacqueline E Schein Angela Tam Tina Wong Inanc Birol Yongjun Zhao Claudia C Faria José Pimentel Sofia Nunes Tarek Shalaby Michael Grotzer Ian F Pollack Ronald L Hamilton Xiao-Nan Li Anne E Bendel Daniel W Fults Andrew W Walter Toshihiro Kumabe Teiji Tominaga V Peter Collins Yoon-Jae Cho Caitlin Hoffman David Lyden Jeffrey H Wisoff James H Garvin Duncan S Stearns Luca Massimi Ulrich Schüller Jaroslav Sterba Karel Zitterbart Stephanie Puget Olivier Ayrault Sandra E Dunn Daniela P C Tirapelli Carlos G Carlotti Helen Wheeler Andrew R Hallahan Wendy Ingram Tobey J MacDonald Jeffrey J Olson Erwin G Van Meir Ji-Yeoun Lee Kyu-Chang Wang Seung-Ki Kim Byung-Kyu Cho Torsten Pietsch Gudrun Fleischhack Stephan Tippelt Young Shin Ra Simon Bailey Janet C Lindsey Steven C Clifford Charles G Eberhart Michael K Cooper Roger J Packer Maura Massimino Maria Luisa Garre Ute Bartels Uri Tabori Cynthia E Hawkins Peter Dirks Eric Bouffet James T Rutka Robert J Wechsler-Reya William A Weiss Lara S Collier Adam J Dupuy Andrey Korshunov David T W Jones Marcel Kool Paul A Northcott Stefan M Pfister David A Largaespada Andrew J Mungall Richard A Moore Nada Jabado Gary D Bader Steven J M Jones David Malkin Marco A Marra Michael D Taylor

Nature 2016 Jan 13;529(7586):351-7. Epub 2016 Jan 13.

Developmental &Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature16478DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936195PMC
January 2016

Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.

Neuro Oncol 2015 Nov 30;17(11):1504-13. Epub 2015 Jun 30.

Royal Melbourne Hospital, Parkville, Australia (K.M.F, P.M.P, M.A.R.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia (J.S., C.S.B.B., E.H.B, K.S., A.L.); Sir Charles Gairdner Hospital, Nedlands, Australia (A.K.N); School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia (A.K.N); Austin Health, Heidelberg, Australia (L.C., G.F.); Royal North Shore Hospital, St Leonards, Australia (H.W.); Prince of Wales Hospital, Randwick, Australia (E.J.H); University of New South Wales, Sydney, Australia (E.J.H); Monash Medical Centre, Clayton, Australia (R.F.); Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia (P.M.P., M.A.R., G.F.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/17/11/1504.
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648304PMC
November 2015

Predictors of distress and poorer quality of life in High Grade Glioma patients.

Patient Educ Couns 2015 Apr 14;98(4):525-32. Epub 2015 Jan 14.

Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2015.01.002DOI Listing
April 2015

Molecular heterogeneity in glioblastoma: potential clinical implications.

Front Oncol 2015 3;5:55. Epub 2015 Mar 3.

Bill Walsh Translational Cancer Research Laboratory, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney , St Leonards, NSW , Australia ; Department of Medical Oncology, Royal North Shore Hospital , St Leonards, NSW , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347445PMC
March 2015

Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.

Neurooncol Pract 2015 Mar 15;2(1):48-53. Epub 2014 Dec 15.

Northern Sydney Cancer Centre , Royal North Shore Hospital , Sydney , Australia (M.B., C.G., M.K., L.G., H.W.); Northern Clinical School, Sydney Medical School , University of Sydney , Sydney , Australia (M.B., C.G., H.W.).

View Article

Download full-text PDF

Source
https://academic.oup.com/nop/article-lookup/doi/10.1093/nop/
Publisher Site
http://dx.doi.org/10.1093/nop/npu031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369710PMC
March 2015

Antiangiogenic therapy for high-grade glioma.

Cochrane Database Syst Rev 2014 Sep 22(9):CD008218. Epub 2014 Sep 22.

NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD008218.pub3DOI Listing
September 2014

Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide Chemotherapy.

Transl Oncol 2013 Dec 1;6(6):742-8. Epub 2013 Dec 1.

Bill Walsh Translational Cancer Research Laboratory, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia ; University of Sydney, Sydney, New South Wales, Australia ; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia ; Sydney Neuro-Oncology Group, North Shore Private Hospital, St Leonards, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890709PMC
http://dx.doi.org/10.1593/tlo.13553DOI Listing
December 2013

Expanding the spectrum of IDH1 mutations in gliomas.

Mod Pathol 2013 May 11;26(5):619-25. Epub 2013 Jan 11.

Department of Neuropathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.210DOI Listing
May 2013

Dehiscence of corticosteroid-induced abdominal striae in a 14-year-old boy treated with bevacizumab for recurrent glioblastoma.

J Child Neurol 2012 Jul 21;27(7):927-9. Epub 2011 Dec 21.

Department of Medical Oncology, Royal North Shore Hospital, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0883073811428007
Publisher Site
http://dx.doi.org/10.1177/0883073811428007DOI Listing
July 2012

miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.

Eur J Cancer 2011 Apr 31;47(6):953-63. Epub 2010 Dec 31.

Cerebral Tumour Research Group, Hormones and Cancer, Kolling Institute of Medical Research, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.11.026DOI Listing
April 2011

Schwannomatosis, sporadic schwannomatosis, and familial schwannomatosis: a surgical series with long-term follow-up. Clinical article.

J Neurosurg 2011 Mar 8;114(3):756-62. Epub 2010 Oct 8.

Department of Neurosurgery, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2010.8.JNS091900DOI Listing
March 2011

The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20 years' experience at a single centre.

J Clin Neurosci 2011 Mar 17;18(3):329-33. Epub 2011 Jan 17.

Cerebral Tumour Research Laboratory, Hormones and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Pacific Highway, St Leonards, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2010.07.101DOI Listing
March 2011

Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma.

J Clin Neurosci 2010 Aug 3;17(8):993-6. Epub 2010 Jun 3.

Sydney Medical School, The University of Sydney, New South Wales 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2009.12.015DOI Listing
August 2010

Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?

J Clin Neurosci 2009 Jun 20;16(6):854-5. Epub 2009 Mar 20.

Department of Medical Oncology, Royal North Shore Hospital, Pacific Highway, St Leonards, New South Wales 2065, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2008.09.005DOI Listing
June 2009

Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma.

Mol Cancer Ther 2008 Oct;7(10):3420-8

Hormones and Cancer Group, Cancer Genetics Laboratory, Kolling Institute of Medical Research, Reserve Road, St. Leonards, New South Wales, 2065 Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-08-0629DOI Listing
October 2008

Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma.

J Neurooncol 2008 Mar 15;87(1):71-8. Epub 2007 Nov 15.

Cancer Genetics Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, NSW 2065, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-007-9486-0DOI Listing
March 2008

Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma.

J Clin Neurosci 2008 Jan 26;15(1):1-8. Epub 2007 Nov 26.

Cancer Genetics Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2007.06.005DOI Listing
January 2008